COVID-19 for the Cardiologist : Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies
© 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation..
Coronavirus disease-2019 (COVID-19), a contagious disease caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has reached pandemic status. As it spreads across the world, it has overwhelmed health care systems, strangled the global economy, and led to a devastating loss of life. Widespread efforts from regulators, clinicians, and scientists are driving a rapid expansion of knowledge of the SARS-CoV-2 virus and COVID-19. The authors review the most current data, with a focus on the basic understanding of the mechanism(s) of disease and translation to the clinical syndrome and potential therapeutics. The authors discuss the basic virology, epidemiology, clinical manifestation, multiorgan consequences, and outcomes. With a focus on cardiovascular complications, they propose several mechanisms of injury. The virology and potential mechanism of injury form the basis for a discussion of potential disease-modifying therapies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
JACC. Basic to translational science - 5(2020), 5 vom: 05. Mai, Seite 518-536 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Atri, Deepak [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 11.11.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.jacbts.2020.04.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308778251 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308778251 | ||
| 003 | DE-627 | ||
| 005 | 20231225132454.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jacbts.2020.04.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1029.xml |
| 035 | |a (DE-627)NLM308778251 | ||
| 035 | |a (NLM)32292848 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Atri, Deepak |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 for the Cardiologist |b Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.11.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation. | ||
| 520 | |a Coronavirus disease-2019 (COVID-19), a contagious disease caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has reached pandemic status. As it spreads across the world, it has overwhelmed health care systems, strangled the global economy, and led to a devastating loss of life. Widespread efforts from regulators, clinicians, and scientists are driving a rapid expansion of knowledge of the SARS-CoV-2 virus and COVID-19. The authors review the most current data, with a focus on the basic understanding of the mechanism(s) of disease and translation to the clinical syndrome and potential therapeutics. The authors discuss the basic virology, epidemiology, clinical manifestation, multiorgan consequences, and outcomes. With a focus on cardiovascular complications, they propose several mechanisms of injury. The virology and potential mechanism of injury form the basis for a discussion of potential disease-modifying therapies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a ACE2, angiotensin-converting enzyme 2 | |
| 650 | 4 | |a ARDS, acute respiratory distress syndrome | |
| 650 | 4 | |a CFR, case fatality rate | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a COVID-19, coronavirus disease-2019 | |
| 650 | 4 | |a CoV, coronavirus | |
| 650 | 4 | |a DIC, disseminated intravascular coagulation | |
| 650 | 4 | |a ER, endoplasmic reticulum | |
| 650 | 4 | |a ICU, intensive care unit | |
| 650 | 4 | |a SARS-CoV, severe acute respiratory syndrome-coronavirus | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a SOFA, sequential organ failure assessment | |
| 650 | 4 | |a TMPRSS2, transmembrane serine protease 2 | |
| 650 | 4 | |a cardiovascular | |
| 650 | 4 | |a hsCRP, high-sensitivity C-reactive protein | |
| 650 | 4 | |a treatments | |
| 650 | 4 | |a virology | |
| 700 | 1 | |a Siddiqi, Hasan K |e verfasserin |4 aut | |
| 700 | 1 | |a Lang, Joshua P |e verfasserin |4 aut | |
| 700 | 1 | |a Nauffal, Victor |e verfasserin |4 aut | |
| 700 | 1 | |a Morrow, David A |e verfasserin |4 aut | |
| 700 | 1 | |a Bohula, Erin A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JACC. Basic to translational science |d 2016 |g 5(2020), 5 vom: 05. Mai, Seite 518-536 |w (DE-627)NLM258427175 |x 2452-302X |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2020 |g number:5 |g day:05 |g month:05 |g pages:518-536 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jacbts.2020.04.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2020 |e 5 |b 05 |c 05 |h 518-536 | ||